Exploring the potential of animal venoms for medical treatments
Official title: 2024 Venom Evolution, Function and Biomedical Applications Gordon Research Conference and Gordon Research Seminar
Funded at Gordon Research Conferences · NIH-11000157 · Data updated 2026-11-12
This study is exploring the unique properties of animal venoms to find new ways to treat human diseases, especially for people affected by snakebites, with the hope of creating better medications from these natural toxins.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gordon Research Conferences NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $29,850 |
| NIH project number | 1R13AT013028-01 |
| Project ID | NIH-11000157 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals suffering from conditions that could be treated with venom-derived therapies, such as snakebite victims or patients with specific medical needs addressed by these compounds.
✕Less likely to help
Patients who do not have conditions related to venom-derived treatments or those who are not affected by snakebite envenoming may not receive any benefit from this research.
What this research studies
This research focuses on the diverse and complex nature of animal venoms, which contain bioactive compounds known as toxins. By studying the molecular structure and targets of these toxins, researchers aim to discover new therapeutic applications for treating various human diseases. The project highlights the evolutionary significance of venoms and their potential in developing effective treatments, particularly for conditions like snakebite envenoming. Patients may benefit from advancements in venom-derived therapies that could lead to new medications.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments derived from animal venoms for various medical conditions.
How similar studies have gone: Previous research has shown success in developing venom-derived drugs, indicating that this approach has potential for significant advancements in medical treatment.
Where this research is happening
-
Gordon Research Conferences
East Greenwich, United States Active
Researchers
- Principal investigator: Mackessy, Stephen P — Gordon Research Conferences
- Study coordinator: Mackessy, Stephen P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.